All Stories

  1. Potential modification of the UKPDS risk engine and evaluation of macrovascular event rates in controlled clinical trials

    Article • Diabetes Metabolic Syndrome and Obesity, July 2013, Dove Medical Press

    Dr Kenneth Pomerantz, Dr Kenneth Pomerantz